Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Parkinson's disease | R-HSA-1643685 | 0 | SC-19220 | 2782 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | SC-19220 | 2782 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | SC-19220 | 2782 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | SC-19220 | 2782 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | SC-19220 | 2782 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | SC-19220 | 2782 | drug-path |
| Asthma | R-HSA-444620 | map05310 | SC-19220 | 2782 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | SC-19220 | 2782 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | SC-19220 | 2782 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | SC-19220 | 2782 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | perphenazine | 4748 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | perphenazine | 4748 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | perphenazine | 4748 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | danazol | 28417 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | danazol | 28417 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | danazol | 28417 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | danazol | 28417 | drug-path |
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | lynestrenol | 5857 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | lynestrenol | 5857 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | lynestrenol | 5857 | drug-path |